Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
Under the current system, PBMs act as middlemen between manufacturers, insurers and pharmacies - inflating drug prices at the expense of patients with complex rebate and pricing structures. In ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
A drug pricing expert reveals the shocking cost disparity of a life-saving spinal muscular atrophy drug in India, priced at ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...
Hawaii has another opportunity to seek damages against the country’s three largest pharmacy benefit managers over alleged ...
The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin. She was speaking just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback